PATENT CLAIM ANALYSIS

Application Number: 16135729
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "273400"]

Abstract:
Described are N-(6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-yl)benzamide and acetamide-containing compounds that inhibit WDR5 and associated protein-protein interactions, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.

Claim (Index 7):
The compound of any of  claims 1 - 6 , or a pharmaceutically acceptable salt thereof, wherein X 2  is CH 2 .

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.28947
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15703289', '14206028', '13828285', '14392200', '13548785']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7782085480684408
- 35 USC 102 Novelty (BERT): 0.5602980879862889
- Combined Prediction Score: 0.7564175020602255
- Mean Citation Score: 349.4888620000001
- Max Citation Score: 432.6185
- Similarity Product: 347.21237351837755

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test